Could Roche Put a Crinkle in Biogen's Alzheimer's Drug Launch?

Could Roche Put a Crinkle in Biogen's Alzheimer's Drug Launch?

Source: 
Motley Fool
snippet: 
  • Roche could launch its Alzheimer's disease drug gantenerumab at a discount to Biogen's Aduhelm.
  • The Swiss pharma still needs to gain FDA approval for its drug.